← all drugs
Methotrexate Injection
being discontinued · Rheumatology · Snapshot: 2026-08-25
- Manufacturers listed
- Assertio Specialty Pharmaceuticals, LLC
- Machine-readable
- JSON for this drug
Presentations (7)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Otrexup, Injection, 12.5 mg/.4 mL (NDC 82497-012-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
| Otrexup, Injection, 15 mg/.4 mL (NDC 82497-015-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
| Otrexup, Injection, 17.5 mg/.4 mL (NDC 82497-017-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
| Otrexup, Injection, 22.5 mg/.4 mL (NDC 82497-022-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
| Otrexup, Injection, 10 mg/.4 mL (NDC 82497-010-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
| Otrexup, Injection, 20 mg/.4 mL (NDC 82497-020-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
| Otrexup, Injection, 25 mg/.4 mL (NDC 82497-025-04) | Assertio Specialty Pharmaceuticals, LLC | unknown | 08/29/2025 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.